System Burdens of Polycythemia Vera

Laura C. Michaelis, MD

Video Categories: Polycythemia Vera

Listen as Dr. Michaelis discusses the unique aspects of the system burdens of polycythemia vera, the difficult approach to treat and the options to treat.

Supported through funding from Incyte
January 16, 2019

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

December 12, 2016

Patient Preferences

Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.